ehdotus on tarpeeksi Troubled teva pharmaceuticals major shareholders auringonpolttama Laiska Säännöllisyys
Chairman of pharmaceutical giant Teva to resign | The Times of Israel
Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry | IntechOpen
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
With 61% ownership of the shares, Teva Pharmaceutical Industries Limited (NYSE:TEVA) is heavily dominated by institutional owners - Simply Wall St News
DEF 14A
Definitive Proxy Statement
What Kind Of Shareholders Hold The Majority In Teva Pharmaceutical Industries Limited's (NYSE:TEVA) Shares?
What Kind Of Investor Owns Most Of Teva Pharmaceutical Industries Limited (NYSE:TEVA)?
Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
Teva slide could draw vultures but it won't be easy prey | The Times of Israel
Buyers remorse or fraud? Teva and Mexican brothers slug it out over sour deal
Teva Pharmaceutical Industries Settles $420 Million Shareholder Lawsuit
Takeda Announces Details of New Business Venture with Teva in Japan